144 Results for "

Interleukin-1 Receptor

" in MedChemExpress (MCE) Product Catalog:
Products (144)

144 Results for "Interleukin-1 Receptor" in MCE Product Catalog:

56
56 Publications Verification
Cat. No.: HY-108841
CAS No.: 143090-92-0
Purity:  99.40%
Synonyms: Kineret; Anakinra
Raleukin (Kineret) is a recombinant, nonglycosylated human interleukin-1 receptor (IL-1R) antagonist. Raleukin significantly reduces neutrophil accumulation in blood vessels and brain infarct volume as well as improves motor coordination performance in ischemic stroke mice model. Anakinra can be used to study chronic inflammatory disorders like rheumatoid arthritis and cardiovascular recurrence post-myocardial infarction .
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-13329
CAS No.: 509093-47-4
Purity:  99.90%
Synonyms: IRAK-1/4 Inhibitor I
Target:  

IRAK

Research Areas:  

Inflammation/Immunology

IRAK-1-4 Inhibitor I is an inhibitor of interleukin-1 receptor-associated kinase 1/4 (IRAK 1/4) with IC50s of 0.2 μM and 0.3 μM, respectively.
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-P72566
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IL1RN; IL-1ra; Interleukin 1 Receptor Antagonist; Intracellular Interleukin-1 Receptor Antagonist (IcIL-1ra); ICIL-1RA; Intracellular Interleukin-1 Receptor Antagonist; IL-1RN; Intracellular IL-1 Receptor Antagonist Type II; IL1RA; Type II Interleukin-1 R
Species:  
Source:  
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-19836
CAS No.: 1817626-54-2
Synonyms: PF-06650833
Target:  

IRAK

Research Areas:  

Inflammation/Immunology

Zimlovisertib (PF-06650833) is a potent, selective and orally active inhibitor of interleukin-1 receptor associated kinase 4 (IRAK4) with IC50s of 0.2 and 2.4 nM in the cell and PBMC assay, respectively. Zimlovisertib is used to treat diseases such as rheumatoid arthritis, lupus, and lymphomas .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-103017
CAS No.: 2591344-30-6
Purity:  99.14%
Target:  

IRAK

Research Areas:  

Infection

JH-X-119-01 hydrochloride is a potent and selective interleukin-1 receptor-associated kinases 1 (IRAK1) inhibitor. JH-X-119-01 hydrochloride ameliorates LPS-induced sepsis in mice .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-103017A
CAS No.: 2227368-54-7
Purity:  99.03%
Target:  

IRAK

JH-X-119-01 is a potent and selective interleukin-1 receptor-associated kinases 1 (IRAK1) inhibitor. JH-X-119-01 ameliorates LPS-induced sepsis in mice . JH-X-119-01 inhibits IRAK1 biochemically with an apparent IC50 of 9 nM while exhibiting no inhibition of IRAK4 at concentrations up to 10 μM .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-P1110
CAS No.: 185413-30-3
Target:  

Interleukin Related

Research Areas:  

Inflammation/Immunology

AF12198 is a potent, selective and specific peptide antagonist for human type I interleukin-1 receptor (IL1-R1) (IC50=8 nM) but not the human type II receptor (IC50=6.7 µM) or the murine type I receptor (IC50>200 µM). AF12198 inhibits IL-1-induced IL-8 production (IC50=25 nM) and IL-1-induced intercellular adhesion molecule-1 (ICAM-1) expression (IC50=9 nM) in vitro. AF12198 has anti-inflammatory activities and blocks responses to IL-1 in vivo .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-P7029
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IL1RN; IL-1ra; Interleukin 1 Receptor Antagonist; Intracellular Interleukin-1 Receptor Antagonist (IcIL-1ra); ICIL-1RA; Intracellular Interleukin-1 Receptor Antagonist; IL-1RN; Intracellular IL-1 Receptor Antagonist Type II; IL1RA; Type II Interleukin-1 R
Species:  
Source:  
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P7029A
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IL1RN; IL-1ra; Interleukin 1 Receptor Antagonist; Intracellular Interleukin-1 Receptor Antagonist (IcIL-1ra); ICIL-1RA; Intracellular Interleukin-1 Receptor Antagonist; IL-1RN; Intracellular IL-1 Receptor Antagonist Type II; IL1RA; Type II Interleukin-1 R
Species:  
Source:  
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P72570
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IL1F10; MGC119832; Interleukin 1 Family Member 10; MGC119833; IL-1HY2; MGC11983; IL1-Theta; IL1HY2; IL-1F10; Interleukin-1 Receptor Antagonist-Like FIL1 Theta; FKSG75; Interleukin 1 Family, Member 10 (Theta); IL-38; Interleukin 1 Family Member 10 (Theta)
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-111101
CAS No.: 2196204-23-4
Purity:  98.07%
Target:  

IRAK

Research Areas:  

Cancer

AZ1495, a weak base, is a potent orally active interleukin-1 receptor associated kinase 4 (IRAK4) inhibitor. AZ1495 has a favorable physicochemical and kinase selectivity for IRAK4 and IRAK1 with IC50 values of 0.005 μM and 0.023 μM, respectively. AZ1495 has IRAK4 inhibition with a Kd value of 0.0007 μM. AZ1495 can be used for the research of diffuse large B-cell lymphoma (DLBCL) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-114181
CAS No.: 1850276-58-2
Purity:  99.55%
Research Areas:  

Inflammation/Immunology

IRAK4-IN-4 (Compound 15) is an interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor, with an IC50 of 2.8 nM. IRAK4-IN-4 also inhibits cyclic GMP-AMP synthase (cGAS) with an IC50 of 2.1 nM. IRAK4-IN-4 can be used for research of autoimmune diseases .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-13278
CAS No.: 1012104-68-5
Purity:  99.77%
Target:  

IRAK

Research Areas:  

Inflammation/Immunology

IRAK inhibitor 4 is an interleukin-1 receptor associated kinase 4(IRAK4) inhibitor.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-13277
CAS No.: 1012343-93-9
Purity:  98.86%
Target:  

IRAK

Research Areas:  

Inflammation/Immunology

IRAK inhibitor 3 is an interleukin-1 (IL-I) receptor-associated kinase (IRAK) kinase modulator extracted from patent WO2008030579 A2.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P70615
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IL1RL1; ST2V; Interleukin 1 Receptor Like 1; Homolog Of Mouse Growth Stimulation-Expressed; DER4; Suppressor Of Tumorigenicity 2; ST2; Interleukin 1 Receptor-Like 1 Isoform 2; T1; Interleukin 1 Receptor-Like 1 Isoform 1; Interleukin-1 Receptor-Like 1; Int
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P71601Y
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: IL1F10; MGC119832; Interleukin 1 Family Member 10; MGC119833; IL-1HY2; MGC11983; IL1-Theta; IL1HY2; IL-1F10; Interleukin-1 Receptor Antagonist-Like FIL1 Theta; FKSG75; Interleukin 1 Family, Member 10 (Theta); IL-38; Interleukin 1 Family Member 10 (Theta)
Species:  
Source:  
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P81134
Synonyms: Toll-like Receptor 2; Toll like Receptor 2; Toll like Receptor 2 precursor; Toll-like Receptor 2; TLR 2; TLR-2; Toll/Interleukin-1 Receptor-like protein 4; CD282 antigen; CD282; TIL 4; TIL4; TLR2_HUMAN; Toll/Interleukin 1 Receptor like 4; Toll/Interleukin 1 Receptor like protein 4; Toll/Interleukin Receptor like protein 4.

Host:  

Rabbit

Application:  

WB, ICC/IF, FC

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P73591
Purity:  ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: TLR2; CD282; Toll Like Receptor 2; Toll/Interleukin-1 Receptor-Like Protein 4; Toll-Like Receptor 2; Toll-Like Receptor; TIL4; CD282 Antigen
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-101922
CAS No.: 1820787-94-7
Purity:  99.88%
Target:  

IRAK

Research Areas:  

Inflammation/Immunology

IRAK4-IN-1 is an interleukin-1 receptor associated kinase 4 (IRAK4) inhibitor with an IC50 of 7 nM.
loading...
    loading...
Cat. No.: HY-109585
CAS No.: 1801343-74-7
Purity:  99.36%
Target:  

IRAK

Research Areas:  

Inflammation/Immunology Cancer

IRAK4-IN-7 is a selective, potent and orally active interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor, extracted from patent WO2015104688 (example 1). IRAK4-IN-7 has the potential for cancer and inflammatory diseases treatment .
loading...
    loading...